Point-of-Care Testing for Sexually Transmitted Infections.

[1]  J. Janelle,et al.  Automated Sexual History and Self-Collection of Extragenital Chlamydia and Gonorrhea Improve Detection of Bacterial Sexually Transmitted Infections in People with HIV. , 2022, AIDS patient care and STDs.

[2]  M. Elovitz,et al.  Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses , 2022, Microbiome.

[3]  J. Kaldor,et al.  Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT). , 2022, The Lancet. Global health.

[4]  J. Gibbs,et al.  Access to, usage and clinical outcomes of, online postal sexually transmitted infection services: a scoping review , 2022, Sexually Transmitted Infections.

[5]  I. Chemin,et al.  Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa , 2022, Expert review of molecular diagnostics.

[6]  Chien‐An Sun,et al.  Trichomonas infection in pregnant women: a nationwide cohort study , 2022, Parasitology Research.

[7]  OUP accepted manuscript , 2022, Clinical Infectious Diseases.

[8]  Hawash Y.,et al.  Ease of use and validity testing of a point-of-care fast test for parasitic vaginosis self-diagnosis. , 2021, Tropical biomedicine.

[9]  Lindi Masson,et al.  Rapid Point-of-Care Testing for Genital Tract Inflammatory Cytokine Biomarkers to Diagnose Asymptomatic Sexually Transmitted Infections and Bacterial Vaginosis in Women: Cost Estimation and Budget Impact Analysis , 2021, Sexually transmitted diseases.

[10]  C. Gaydos,et al.  A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men , 2021, Expert review of molecular diagnostics.

[11]  Brian H. Raphael,et al.  At-Home Specimen Self-Collection and Self-Testing for Sexually Transmitted Infection Screening Demand Accelerated by the COVID-19 Pandemic: a Review of Laboratory Implementation Issues , 2021, Journal of clinical microbiology.

[12]  M. Kabir,et al.  Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques , 2021, Infectious disease reports.

[13]  C. Gaydos,et al.  A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States , 2021, Sexually transmitted diseases.

[14]  Alexander Y. Trick,et al.  A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility , 2021, Science Translational Medicine.

[15]  A. Uusküla,et al.  Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia , 2021, Harm Reduction Journal.

[16]  I. Spicknall,et al.  Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. , 2021, Sexually transmitted diseases.

[17]  J. Hodson,et al.  Correlation between Cepheid GeneXpert and Abbott M2000 assays for HIV viral load measurements , 2020, International journal of STD & AIDS.

[18]  R. Norton,et al.  The Laboratory Diagnosis of Syphilis , 1938, Journal of clinical microbiology.

[19]  Michael R. Wierzbicki,et al.  Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study. , 2020, The Lancet. Infectious diseases.

[20]  M. Unemo.  Accurate, rapid, point-of-care tests for sexually transmitted infections. , 2020, Lancet. Infectious Diseases (Print).

[21]  W. Tsai,et al.  Performance of Xpert HPV on Self-collected Vaginal Samples for Cervical Cancer Screening Among Women in South Africa , 2020, Journal of lower genital tract disease.

[22]  A. Cohall,et al.  At Home Testing for Sexually Transmitted Infections During the COVID-19 Pandemic. , 2020, Sexually transmitted diseases.

[23]  S. Dixon,et al.  Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil. , 2020, Value in health regional issues.

[24]  J. Klausner,et al.  Point-of-Care Testing for Sexually Transmitted Infections: A Review of Recent Developments. , 2020, Archives of pathology & laboratory medicine.

[25]  C. Gilks,et al.  Peer-delivered point-of-care testing for Chlamydia trachomatis and Neisseria gonorrhoeae within an urban community setting: a cross-sectional analysis. , 2020, Sexual health.

[26]  Shameka L. Cody,et al.  The Stigma of Sexually Transmitted Infections. , 2020, The Nursing clinics of North America.

[27]  J. Vera,et al.  Point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review protocol. , 2020, JBI evidence synthesis.

[28]  R. Mehrotra,et al.  Evaluation of a Chip-Based, Point-of-Care, Portable, Real-Time Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix in India , 2020, JCO global oncology.

[29]  C. Fairley,et al.  Changing from Clinician-Collected to Self-Collected Throat Swabs for Oropharyngeal Gonorrhea and Chlamydia Screening among Men Who Have Sex with Men , 2020, Journal of Clinical Microbiology.

[30]  S. Luchters,et al.  Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South Africa , 2020, EClinicalMedicine.

[31]  C. Gaydos,et al.  Point-by-Point Progress: Gonorrhea Point of Care Tests , 2020, Expert review of molecular diagnostics.

[32]  C. Gaydos,et al.  Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea , 2020, JAMA network open.

[33]  T. Ellman,et al.  Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening , 2020, PloS one.

[34]  C. Cartwright,et al.  Prevalence of Mycoplasma genitalium infection in women with bacterial vaginosis , 2020, BMC Women's Health.

[35]  M. Nyirenda,et al.  Diagnostic evaluation of the BD Affirm VPIII assay as a point-of-care test for the diagnosis of bacterial vaginosis, trichomoniasis and candidiasis , 2020, International journal of STD & AIDS.

[36]  M. Unemo,et al.  Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[37]  S. Sayed,et al.  Point-of-care HPV molecular diagnostics for a test-and-treat model in high-risk HIV populations. , 2020, The Lancet. Global health.

[38]  C. Chan,et al.  Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current Perspectives , 2019, Journal of oncology.

[39]  T. Trikalinos,et al.  Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  M. Bala,et al.  Evaluation of reliability of self-collected vaginal swabs over physician-collected samples for diagnosis of bacterial vaginosis, candidiasis and trichomoniasis, in a resource-limited setting: a cross-sectional study in India , 2019, BMJ Open.

[41]  D. Whiley,et al.  Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae. , 2019, The Journal of antimicrobial chemotherapy.

[42]  Kimberley A Foley,et al.  Tools for the Diagnosis of Herpes Simplex Virus 1/2: Systematic Review of Studies Published Between 2012 and 2018 , 2019, JMIR public health and surveillance.

[43]  P. Drain,et al.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response , 2019, Clinical Microbiology Reviews.

[44]  Marra S Francis,et al.  Results of Comprehensive Sexually Transmitted Disease Testing Utilizing an At-Home Kit Over One Year [27J] , 2019, Obstetrics & Gynecology.

[45]  C. Kennedy,et al.  Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: a systematic review and meta-analysis , 2019, BMJ Global Health.

[46]  N. Kiwanuka,et al.  Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda. , 2019, AIDS research and human retroviruses.

[47]  K. Looker,et al.  Online testing for sexually transmitted infections: A whole systems approach to predicting value , 2019, PloS one.

[48]  Katrien Fransen,et al.  Laboratory evaluation of four HIV/syphilis rapid diagnostic tests , 2019, BMC Infectious Diseases.

[49]  B. Van Der Pol.  Making the Most of Point-of-care Testing for Sexually Transmitted Diseases. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  Debrah I. Boeras,et al.  REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes , 2018, Nature Microbiology.

[51]  M. Mwasekaga,et al.  Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube , 2018, PloS one.

[52]  D. J. Shin,et al.  Direct-qPCR Assay for Coupled Identification and Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae. , 2018, ACS infectious diseases.

[53]  S. Philip,et al.  A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  N. Longford,et al.  Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits , 2017, International journal of STD & AIDS.

[55]  G. Horsman,et al.  High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003–15): time to consider point-of-care or molecular testing for precision treatment? , 2018, The Journal of antimicrobial chemotherapy.

[56]  R. Peeling,et al.  Advancing point of care diagnostics for the control and prevention of STIs: the way forward , 2017, Sexually Transmitted Infections.

[57]  D. Ferris,et al.  Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women , 2017, Journal of Clinical Microbiology.

[58]  G. Whitlock,et al.  A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy , 2017, bioRxiv.

[59]  Suzanna C Francis,et al.  Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.

[60]  J. R. Nansseu,et al.  Failure to return to receive HIV-test results: the Cameroon experience , 2017, BMC Research Notes.

[61]  R. McClelland,et al.  Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium , 2017, American journal of epidemiology.

[62]  R. Peeling,et al.  Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men , 2017, Sexually Transmitted Infections.

[63]  Y. Hsieh,et al.  Mobile nucleic acid amplification testing (mobiNAAT) for Chlamydia trachomatis screening in hospital emergency department settings , 2017, Scientific Reports.

[64]  M. Unemo,et al.  Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action , 2017, PLoS medicine.

[65]  M. Rayment,et al.  P101 Cutting the time to treatment of chlamydia trachomatis (CT) and neisseria gonorrhoeae (NG) with near-patient molecular diagnostics: the utility of the cepheid genexpert system , 2017 .

[66]  L. Hanna,et al.  Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections , 2017, Front. Immunol..

[67]  A. Hot,et al.  HIV Point-of-Care Testing in Canadian Settings: A Scoping Review , 2017, Front. Public Health.

[68]  A. Nardone,et al.  Impact of deploying multiple point-of-care tests with a ‘sample first’ approach on a sexual health clinical care pathway. A service evaluation , 2017, Sexually Transmitted Infections.

[69]  Heather M. Draper,et al.  Impact of rapid diagnostic testing for chlamydia and gonorrhea on appropriate antimicrobial utilization in the emergency department. , 2017, Diagnostic microbiology and infectious disease.

[70]  J. Klausner,et al.  Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis screening and treatment of pregnant women in Port-au-Prince, Haiti , 2017, International journal of STD & AIDS.

[71]  N. Constantine,et al.  Assessment of Two Rapid Assays for Diagnostic Capability to Accurately Identify Infection by Treponema pallidum. , 2017, The journal of applied laboratory medicine.

[72]  C. Fairley,et al.  Sensitivity of HIV rapid tests compared with fourth-generation enzyme immunoassays or HIV RNA tests , 2016, AIDS.

[73]  J. Klausner,et al.  A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis , 2016, Infectious diseases in obstetrics and gynecology.

[74]  B. Yu,et al.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae based on cross‐priming amplification , 2016, Letters in applied microbiology.

[75]  D. Klepser,et al.  Community pharmacist-physician collaborative streptococcal pharyngitis management program. , 2016, Journal of the American Pharmacists Association : JAPhA.

[76]  Jennifer S. Smith,et al.  Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women , 2016, Papillomavirus research.

[77]  D. Klepser,et al.  Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. , 2016, Journal of the American Pharmacists Association : JAPhA.

[78]  L. Hoang,et al.  Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis , 2015, PloS one.

[79]  C. Gaydos,et al.  Feasibility and acceptability of point-of-care testing for sexually transmissible infections among men and women in mobile van settings. , 2015, Sexual health.

[80]  Nitika Pant Pai,et al.  Point-of-Care Diagnostic Testing in Global Health: What Is the Point?: The main goal of such testing is to inform caregivers in ways that lead rapidly to their starting correct treatments for patients , 2015 .

[81]  K. Pottie,et al.  Effect of rapid HIV testing on HIV incidence and services in populations at high risk for HIV exposure: an equity-focused systematic review , 2014, BMJ Open.

[82]  M. Morshed,et al.  Recent Trends in the Serologic Diagnosis of Syphilis , 2014, Clinical and Vaccine Immunology.

[83]  G. Whitlock,et al.  Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation , 2014, Sexually Transmitted Infections.

[84]  Justin Hardick,et al.  Point of care diagnostics for sexually transmitted infections: perspectives and advances , 2014, Expert review of anti-infective therapy.

[85]  M. Stoové,et al.  Rapid HIV testing increases the rate of HIV detection in men who have sex with men: using rapid HIV testing in a primary care clinic. , 2014, Sexual health.

[86]  G. Cooke,et al.  Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapy , 2013, Clinical epidemiology.

[87]  Nello Blaser,et al.  Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study , 2013, AIDS.

[88]  M. Maheshwari,et al.  Rapid Point-of-Care Testing for Detection of HIV and Clinical Monitoring , 2013, ISRN AIDS.

[89]  M. Hobbs,et al.  Modern diagnosis of Trichomonas vaginalis infection , 2013, Sexually Transmitted Infections.

[90]  C. Gaydos,et al.  Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2013, Journal of Clinical Microbiology.

[91]  R. Peeling,et al.  Are Treponema pallidum Specific Rapid and Point-of-Care Tests for Syphilis Accurate Enough for Screening in Resource Limited Settings? Evidence from a Meta-Analysis , 2013, PloS one.

[92]  R. Peeling,et al.  The development and validation of dried blood spots for external quality assurance of syphilis serology , 2013, BMC Infectious Diseases.

[93]  J. Kaldor,et al.  Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics , 2012, Sexually Transmitted Infections.

[94]  D. Moodley,et al.  Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[95]  Lin Hu,et al.  Cross Priming Amplification: Mechanism and Optimization for Isothermal DNA Amplification , 2012, Scientific Reports.

[96]  A. Samarawickrama,et al.  A laboratory-based evaluation of the BioStar Optical ImmunoAssay point-of-care test for diagnosing Neisseria gonorrhoeae infection. , 2011, Journal of medical microbiology.

[97]  R. Gray,et al.  Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda , 2011, International journal of STD & AIDS.

[98]  Rochelle P Walensky,et al.  Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions , 2011, BMC medicine.

[99]  Y. Hsieh,et al.  What Qualities Are Most Important to Making a Point of Care Test Desirable for Clinicians and Others Offering Sexually Transmitted Infection Testing? , 2011, PloS one.

[100]  M. Harigopal,et al.  Comparison of Affirm VPIII and Papanicolaou tests in the detection of infectious vaginitis. , 2011, American journal of clinical pathology.

[101]  G. Ramjee,et al.  Epidemiological Synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African Women , 2010, Sexually transmitted diseases.

[102]  T. Quinn,et al.  Mycoplasma genitalium as a Contributor to the Multiple Etiologies of Cervicitis in Women Attending Sexually Transmitted Disease Clinics , 2009, Sexually transmitted diseases.

[103]  M. Golden,et al.  HIV testing in a high-incidence population: is antibody testing alone good enough? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  P. Mayaud,et al.  Rapid Point-of-Care Diagnostic Test for Syphilis in High-Risk Populations, Manaus, Brazil , 2009, Emerging infectious diseases.

[105]  K. Makrilakis,et al.  Clinical Evaluation of Affirm VP III in the Detection and Identification of Bacterial Vaginosis , 2008, Journal of chemotherapy.

[106]  J. Klausner,et al.  Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[107]  D. Church,et al.  Evaluation of the OSOM Trichomonas Rapid Test versus Wet Preparation Examination for Detection of Trichomonas vaginalis Vaginitis in Specimens from Women with a Low Prevalence of Infection , 2008, Journal of Clinical Microbiology.

[108]  Jill S. Huppert,et al.  Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  J. Baeten,et al.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.

[110]  R. Peeling,et al.  Prospective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syphilis , 2006, Sexually Transmitted Infections.

[111]  R. Peeling,et al.  Rapid tests for sexually transmitted infections (STIs): the way forward , 2006, Sexually Transmitted Infections.

[112]  Y. Uyar,et al.  Use of DNA hybridization test for diagnosing bacterial vaginosis in women with symptoms suggestive of infection , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[113]  Wendy S Stevens,et al.  Dried Blood Spots Improve Access to HIV Diagnosis and Care for Infants in Low-Resource Settings , 2005, Journal of acquired immune deficiency syndromes.

[114]  S. Garland,et al.  Evaluation of a Point-of-Care Test, BVBlue, and Clinical and Laboratory Criteria for Diagnosis of Bacterial Vaginosis , 2005, Journal of Clinical Microbiology.

[115]  L. Markowitz,et al.  Evaluation of the Determine Rapid Syphilis TP Assay Using Sera , 2004, Clinical Diagnostic Laboratory Immunology.

[116]  T. Davis,et al.  Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. , 2004, Infectious diseases in obstetrics and gynecology.

[117]  L. Morison,et al.  Evaluation of a New Rapid Diagnostic Kit (FemExam) for Bacterial Vaginosis in Patients With Vaginal Discharge Syndrome in The Gambia , 2003, Sexually transmitted diseases.

[118]  E. Erbelding,et al.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  Tigran Nikoghosyan,et al.  United Nations Children’s Fund (UNICEF) , 2018, Yearbook of International Cooperation on Environment and Development 1998–99.

[120]  A. Pettifor,et al.  How Effective Is Syndromic Management of STDs?: A Review of Current Studies , 2000, Sexually transmitted diseases.

[121]  T. Quinn,et al.  Diagnosis of Trichomonas vaginalisInfection by PCR Using Vaginal Swab Samples , 1998, Journal of Clinical Microbiology.

[122]  D. Eschenbach,et al.  [Bacterial vaginosis]. , 1985, Archives of gynecology.

[123]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .